Stockreport

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development [Read more]